These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 23954180)
1. Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies. Liu YH; Zeng F; Wang YR; Zhou HD; Giunta B; Tan J; Wang YJ Drug Discov Today; 2013 Dec; 18(23-24):1212-20. PubMed ID: 23954180 [TBL] [Abstract][Full Text] [Related]
2. Immunology and immunotherapy of Alzheimer's disease. Weiner HL; Frenkel D Nat Rev Immunol; 2006 May; 6(5):404-16. PubMed ID: 16639431 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in Alzheimer's disease: where do we stand? Where should we go? von Bernhardi R J Alzheimers Dis; 2010; 19(2):405-21. PubMed ID: 20110590 [TBL] [Abstract][Full Text] [Related]
4. The role of the immune system in Alzheimer disease: Etiology and treatment. Jevtic S; Sengar AS; Salter MW; McLaurin J Ageing Res Rev; 2017 Nov; 40():84-94. PubMed ID: 28941639 [TBL] [Abstract][Full Text] [Related]
6. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment. Serpente M; Bonsi R; Scarpini E; Galimberti D Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039 [TBL] [Abstract][Full Text] [Related]
7. New and emerging treatments for Alzheimer's disease. Corbett A; Smith J; Ballard C Expert Rev Neurother; 2012 May; 12(5):535-43. PubMed ID: 22550982 [TBL] [Abstract][Full Text] [Related]
14. Current and emerging therapies for Alzheimer's disease. Nygaard HB Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420 [TBL] [Abstract][Full Text] [Related]
15. Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders. Kayed R; Jackson GR Curr Opin Immunol; 2009 Jun; 21(3):359-63. PubMed ID: 19482462 [TBL] [Abstract][Full Text] [Related]
16. [Inflammation and Alzheimer's disease]. de Toledo M Rev Neurol; 2006 Apr 1-15; 42(7):433-8. PubMed ID: 16602061 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for Alzheimer's disease. Solomon B; Frenkel D Neuropharmacology; 2010; 59(4-5):303-9. PubMed ID: 20388523 [TBL] [Abstract][Full Text] [Related]
19. Improved cognitive and memory abilities in a patient with Alzheimer's disease treated with activated immune cells: Immune cell therapy may benefit more AD patients. Laumbacher B; Fellerhoff-Loesch B; Wank R Med Hypotheses; 2017 Feb; 99():19-22. PubMed ID: 28110690 [TBL] [Abstract][Full Text] [Related]
20. Inflammation of the brain in Alzheimer's disease: implications for therapy. McGeer PL; McGeer EG J Leukoc Biol; 1999 Apr; 65(4):409-15. PubMed ID: 10204568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]